Detalles de la búsqueda
1.
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.
Am J Hematol
; 99(5): 1008-1011, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38425185
2.
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT.
Am J Hematol
; 98(11): 1685-1698, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548390
3.
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
BMC Cancer
; 22(1): 51, 2022 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35012477
4.
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer.
Pancreatology
; 21(8): 1466-1471, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34511398
5.
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer
; 29(9): 5197-5207, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33625586
6.
The Role of Neutrophilic Granulocytes in Philadelphia Chromosome Negative Myeloproliferative Neoplasms.
Int J Mol Sci
; 22(17)2021 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34502471
7.
Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma.
Int J Mol Sci
; 22(9)2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34067112
8.
Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
Int J Mol Sci
; 22(11)2021 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34064196
9.
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1.
Hematol Oncol
; 38(5): 792-798, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32757230
10.
Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.
Eur J Haematol
; 104(3): 251-258, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838747
11.
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence.
Int J Mol Sci
; 21(8)2020 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32325898
12.
Ixazomib-Thalidomide-Dexamethasone for induction therapy followed by Ixazomib maintenance treatment in patients with relapsed/refractory multiple myeloma.
Br J Cancer
; 121(9): 751-757, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31558804
13.
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Eur J Haematol
; 102(5): 437-441, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30725494
14.
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
BMC Cancer
; 18(1): 1074, 2018 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30400780
15.
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Ann Hematol
; 97(10): 1825-1839, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29862437
16.
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Ann Hematol
; 97(9): 1745, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934835
17.
Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera.
Blood
; 126(15): 1762-9, 2015 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26261238
18.
Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.
Ann Hematol
; 96(7): 1155-1162, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28456850
19.
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Br J Cancer
; 115(10): 1264-1272, 2016 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27764838
20.
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and ß2 -microglobulin.
Br J Haematol
; 168(2): 239-45, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25236324